TickerFacts.

Tempest Therapeutics, Inc. (TPST): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2017-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$790.0K
Year ended 2017-12-31
$5.40M2013-12-31: $02014-12-31: $02015-12-31: $2.25M2016-12-31: $5.40M2017-12-31: $790.0K$790.0K
2013-12-31 Cost of Revenue (USD) 2017-12-31
Period endedCost of RevenueChange YoYSource filing
2017-12-31$790.0K-85.4%2018-03-15, From 2017-01-01
2016-12-31$5.40M+140.2%2018-03-15, From 2016-01-01
2015-12-31$2.25Mn/a2018-03-15, From 2015-01-01
2014-12-31$0n/a2017-03-02, From 2014-01-01
2013-12-31$0n/a2016-02-26, From 2013-01-01